| 发明名称 |
PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS |
| 摘要 |
The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis. |
| 申请公布号 |
EP2815769(A4) |
申请公布日期 |
2015.08.19 |
| 申请号 |
EP20130748791 |
申请日期 |
2013.02.15 |
| 申请人 |
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
发明人 |
SEONG, JAE YOUNG;HWANG, JONG IK;SUN, WOONG;CHO, EUN BEE;KIM, WON-KI |
| 分类号 |
A61K48/00;A61K31/7088;A61K31/7105;A61P25/28 |
主分类号 |
A61K48/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
